AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. The state-of-the-art campus will integrate advanced manufacturing and laboratory technologies with artificial intelligence (AI) to support the production of AbbVie’s immunology, neuroscience and oncology medicines.
This is AbbVie’s first major investment in North Carolina. The AbbVie Durham campus, located near Research Triangle Park, was selected for the strength of the region’s local workforce and its ability to support future expansion. Construction will begin this year, with completion expected by the end of 2028.
Over the next four years, AbbVie plans to hire 734 people, including engineers, scientists, manufacturing operators and laboratory technicians. The project will also support the local economy by generating more than 2,000 construction jobs during campus development.
This project is part of the Company’s $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade.
The post Durham Lands $1.4B Pharma Campus appeared first on Connect CRE.
​Â